Olfactory health – how well we are able to smell – is a reliable marker of the health of the brain, but the “smell identification tests” commonly used in studies of olfactory health do not offer a complete picture of what is happening. Now, using a novel PET radiotracer called Neuroflux, a team o...
Search Results: Chronic Liver Disease
Chongzhao Ran
Chongzhao Ran, PhD, is an Associate Professor in Radiology at Massachusetts General Hospital and Harvard Medical School. He received a Master's degree in medicinal chemistry from China Pharmaceutical University and a PhD in medicinal chemistry from Shanghai Institute of Pharmaceutical Industry, C...
Shasha Li
Shasha Li, M.D., Ph.D., joined the faculty at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) with the goal of improving the understanding of the physiological implications of altered neural networks in neurological diseases. She has made substantial contributions to the fie...
Home Hospital Innovation Challenge Showcases Imaging Technologies of Tomorrow
On Thursday, May 18, the MGH Martinos Center for Biomedical Imaging hosted the Home Hospital Innovation Challenge: a Shark Tank-like event in which researchers pitched ideas for novel biomedical imaging technologies that could be commercialized to meet a growing call for hospital-level care provi...
Matthew Rosen
Dr. Matt Rosen is a physicist, tool-builder and inventor whose research bridges the spectrum from fundamental physics to applied bioimaging work in the field of MRI. He established the Low-Field MRI and Hyperpolarized Media Laboratory at the Athinoula A. Martinos Center for Biomedical Imaging to ...
Machine Learning Model Identified Alzheimer’s Disease-Like Structural Brain Patterns in Younger, Asymptomatic Adults
Iman Aganj
Dr. Aganj's research objectives are focused on developing new medical image analysis techniques and improving existing ones so researchers and clinicians can extract the maximal amount of useful information from the images they acquire, with the goal of improving human health. These efforts range...
David Salat
The overarching aim of Dr. Salat's work is to understand mechanisms of neural disease and to implement novel approaches to reduce the impact of disease on the brain, cognition and clinical status. Clinically, there are two main clinical foci to his research. At the MGH Martinos Center, he directs...
Randy Gollub
Randy Gollub, MD, PhD, is Professor of Psychiatry at Harvard Medical School and Clinical Professor of Psychiatry with a secondary appointment in Radiology at Massachusetts General Hospital, where she serves as the Associate Director of Translational Research in the Neuroimaging Research Program. ...
Uncovering ‘Covert Consciousness’ in Brain Injury Patients
In a paper published in the journal Brain last month Brian Edlow and colleagues reported a study in which they used the imaging techniques functional MRI and EEG to detect ‘covert consciousness’ in the intensive care unit. We checked in with Edlow, associate director of the Center for Neurotechno...
Marco Loggia
In 2008, Marco Loggia was awarded a PhD In Neurological Sciences by McGill University in Montreal, QC (Canada). During his graduate studies, he had the opportunity to work at the Alan Edwards Centre for Research on Pain (formerly McGill Centre for Research on Pain) under the mentorship of its fir...
Understanding the Patient-Clinician Relationship with ‘Hyperscanning’ fMRI
The quality of the patient-clinician relationship is widely held to impact a patient’s response to treatment. Exactly how, though, has long remained a mystery. In a study reported in October 2020, Martinos Center researchers began to explore the questions of which parts of the brain and which typ...
As an MGH Research Scholar, Brian Edlow Will Pursue Detection of ‘Covert Consciousness’ in the ICU
Martinos researcher Brian Edlow, MD has been announced as a 2023 MGH Research Scholar. The five-year funding accompanying the honor will support his project, “Detecting Covert Consciousness in the Intensive Care Unit.” Every year, more than one million people across the globe are impacted by sev...
Caterina Mainero
Caterina Mainero, MD, PhD, is an Associate Professor of Radiology at Harvard Medical School, Assistant in Neuroscience at Massachusetts General Hospital and Director of Multiple Sclerosis Research at the Athinoula A. Martinos Center for Biomedical Imaging. Dr. Mainero is a neuroscientist with ...
Heidi Jacobs
The Jacobs Lab aims to detect the earliest brain changes that contribute to cognitive decline and behavioral changes associated with the earliest stages of Alzheimer's disease. Our focus is on neuroimaging method development, biomarker evaluation and testing new preventive interventions targeting...
Changning Wang
Changning Wang, PhD, has a unique and broad background in molecular imaging, medicinal chemistry, pharmaceutical sciences and neuroscience. After finishing his doctoral studies, he joined Martinos Center for Biomedical Imaging as a research fellow and later as a trainee in the Harvard/MGH Nuclear...
Abbas Yaseen
Abbas Yaseen, PhD, is an Assistant Professor of Radiology at Harvard Medical School specializing in advanced microscopy for minimally invasive, in vivo characterization of brain function in preclinical models. His group focuses on the development and application of high-resolution optical imaging...
Marta Bianciardi
Marta Bianciardi, PhD, joined the faculty at Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) with the goal of developing an in vivo neuroimaging-based atlas and connectome of brainstem nuclei by 7 Tesla MRI, to enhance our knowledge and the quality of patient care in disorde...
Sava Sakadzic
Dr. Sakadzic obtained his Ph.D. with Dr. Lihong Wang at Texas A&M University and completed his postdoctoral training with Dr. David Boas at the Massachusetts General Hospital. His group is developing state-of-the-art optical microscopy imaging technologies and utilizing them to better understand ...
The Possible Role of Glow Sticks—Yes, Glow Sticks—in Treating Alzheimer’s
A new imaging probe that could help to advance therapies for Alzheimer’s disease draws its inspiration from an unlikely source. Research suggests that Alzheimer’s is closely associated with increased levels of ‘reactive oxygen species’ (ROS) in the brain, but actual, in vivo evidence of this h...